Anika Therapeutics, Inc.

Anika Therapeutics, Inc. - Enterprise Valueverified

ANIK

Price:

$14.42

Market Cap:

$191.87M

Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform. Their comprehensive product lines feature an OA pain management family, which includes established treatments like Monovisc, Orthovisc, Cingal, and Hyvisc, all designed to alleviate discomfort from osteoarthr...[Read more]

Industry

Medical - Devices

IPO Date

1993-05-03

Stock Exchange

NASDAQ

Ticker

ANIK

The Enterprise Value as of June 2026 (TTM) for Anika Therapeutics, Inc. (ANIK) is 176.58M

According to Anika Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 176.58M. This represents a change of 37.77% compared to the average of 128.17M of the last 4 quarters.

Anika Therapeutics, Inc. (ANIK) Historical Enterprise Value (quarterly & annually)

How has ANIK Enterprise Value performed in the past?

The mean historical Enterprise Value of Anika Therapeutics, Inc. over the last ten years is 425.94M. The current 176.58M Enterprise Value has changed 4.05% with respect to the historical average. Over the past ten years (40 quarters), ANIK's Enterprise Value was at its highest in in the September 2017 quarter at 718.62M. The Enterprise Value was at its lowest in in the September 2025 quarter at 102.06M.

Quarterly (TTM)
Annual

Average

425.94M

Median

419.45M

Minimum

106.56M

Maximum

652.48M

Anika Therapeutics, Inc. (ANIK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Anika Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 50.68%

Maximum Annual Enterprise Value = 652.48M

Minimum Annual Increase = -49.88%

Minimum Annual Enterprise Value = 106.56M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025106.56M-49.88%
2024212.61M-26.96%
2023291.11M-22.49%
2022375.57M-15.14%
2021442.56M-22.41%
2020570.34M-4.50%
2019597.22M50.68%
2018396.35M-39.25%
2017652.48M6.17%
2016614.57M33.84%

Anika Therapeutics, Inc. (ANIK) Average Enterprise Value

How has ANIK Enterprise Value performed in the past?

The current Enterprise Value of Anika Therapeutics, Inc. (ANIK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

203.43M

5-year avg

285.68M

10-year avg

425.94M

Anika Therapeutics, Inc. (ANIK) Enterprise Value vs. Peers

How is ANIK’s Enterprise Value compared to its peers?

Anika Therapeutics, Inc.’s Enterprise Value is greater than Owlet, Inc. (68.23M), greater than LENSAR, Inc. (59.56M), less than Apyx Medical Corporation (180.43M), greater than Anteris Technologies Global Corp. (80.32M), greater than Lucid Diagnostics Inc. (109.42M), greater than Rapid Micro Biosystems, Inc. (87.40M), greater than Anixa Biosciences, Inc. (97.71M), less than Accuray Incorporated (185.72M), greater than MaxCyte, Inc. (132.55M), greater than Quipt Home Medical Corp. (104.44M),

Build a custom stock screener for Anika Therapeutics, Inc. (ANIK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anika Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anika Therapeutics, Inc. (ANIK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anika Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Anika Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Anika Therapeutics, Inc. (ANIK)?

What is the 3-year average Enterprise Value for Anika Therapeutics, Inc. (ANIK)?

What is the 5-year average Enterprise Value for Anika Therapeutics, Inc. (ANIK)?

How does the current Enterprise Value for Anika Therapeutics, Inc. (ANIK) compare to its historical average?